


























































published: 20 November 2014
doi: 10.3389/fped.2014.00126
Incidental histological diagnosis of acute rheumatic
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Rheumatic fever (RF) remains endemic in many countries and frequently causes heart
failure due to severe chronic rheumatic valvular heart disease, which requires surgical
treatment. Here, we report on a patient who underwent an elective surgical correction
for mitral and aortic valvular heart disease and had a post-operative diagnosis of acute
rheumatic carditis. The incidental finding of Aschoff bodies in myocardial biopsies is fre-
quently reported in the nineteenth-century literature, with prevalences as high as 35%, but
no clinical or prognostic data on the patients is included.The high frequency of this finding
after cardiac surgery in classical reports suggests that these patients were not using sec-
ondary prophylaxis for RF. We discuss the clinical diagnosis of acute rheumatic myocarditis
in asymptomatic patients and the laboratorial and imaging methods for the diagnosis of
acute rheumatic carditis. We also discuss the prognostic implications of this finding and
review the related literature.
Keywords: acute rheumatic fever,Aschoff’s body, rheumatic myocarditis, rheumatic fever, diagnosis of myocarditis,
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BACKGROUND
Rheumatic fever (RF) remains endemic in many countries and
frequently causes heart failure due to severe chronic rheumatic
valvular heart disease, which requires surgical treatment. Another
mechanism of heart failure in rheumatic patients is acute
rheumatic myocarditis (1). Acute rheumatic myocarditis is a dif-
ficult and misleading diagnosis that is often forgotten in patients
with severe combined valvular heart disease. Here, we report on a
patient who underwent an elective surgical correction for mitral
and aortic valvular disease and had a post-operative diagnosis of
acute rheumatic carditis.
CASE REPORT
Case report: a 45-year-old female patient with previous diagnoses
of hypertension, diabetes, hypothyroidism, and chronic rheumatic
valve disease was seen as an outpatient; she reported a 3-year his-
tory of progressive exertional dyspnea and chest pain. She also
reported orthopnea and paroxysmal nocturnal dyspnea and was
taking 25 mg/day of atenolol.
A physical examination revealed a blood pressure of 140 over
80 mmHg and a regular heart rate of 80 bpm, which was typically
parvus et tardus. Her cardiac auscultation presented a +++/6+
(according to the Levine classification) mid-systolic ejection mur-
mur in the aortic area and a++/6+ diastolic rumble in the mitral
area. The pulmonary and abdominal examinations revealed no
abnormalities.
A 12-lead electrocardiogram revealed left atrial and left ventric-
ular (LV) hypertrophy. A chest X-ray showed left atrial enlarge-
ment, a normal LV size, and signs of pulmonary congestion evi-
denced by Kerley B lines. Transthoracic echocardiography showed
that the LV diastolic diameter was 49 mm, the LV systolic diameter
was 32 mm, the interventricular septum was 11 mm, the poste-
rior wall was 12 mm, the LV ejection fraction was 72% and there
were diagnoses of aortic stenosis with a peak systolic gradient of
82 mmHg, and mitral stenosis with a mitral valve area of 1.1 cm2.
The patient was referred to surgery for her chronic rheumatic
heart disease with mitral and aortic stenosis and NYHA func-
tional class III. Preoperative coronary angiotomography revealed
a calcium score of 0 and no coronary disease.
Surgery was performed, and the patient underwent mitral and
aortic replacement with mechanical prostheses. Her recovery from
the surgery was uneventful.
The histopathological report of the surgical specimens revealed
the presence of Aschoff bodies in the proliferative phase, which is
suggestive of acute RF (Figure 1). In addition, an examination of
the valves showed characteristics of chronic rheumatic heart dis-
ease involvement and the presence of Anitschkow cells (Figure 1),
valvular fibrosis, calcification, and neovascularization.
The histopathological findings led to the unexpected diagnosis
of acute RF with myocarditis. Before histopathologic results were
available, symptoms such as tachycardia and worsening of heart
failure symptoms were thought to be due only to the underly-
ing valvular heart disease. The diagnosis of rheumatic myocarditis
allowed for a more complete treatment of the patient, with intro-
duction of prednisone (60 mg daily) and resuming of secondary
prophylaxis for RF with benzathine penicillin G 1.200.000 UI
intramuscularly every 3 weeks. Even after cardiac surgery, she still
presented tachycardia and exertional dyspnea, symptoms that may
be suggestive of myocarditis because other causes were excluded.
The combined treatment of the valvular heart disease and
the myocarditis led to a complete resolution of symptoms, with
resolution of the heart failure and tachycardia symptoms within
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FIGURE 1 | Histopathological findings – Aschoff nodules (arrows) in
samples of myocardium from the papillary muscles of the excised
mitral valve (A). The arrows in sample (B) indicate Anitschkow cells. Photo
courtesy of Dr. Lea M. M. F. Demarchi from the Laboratory of Pathology,
Heart Institute (InCor), University of São Paulo Medical School.
2 weeks after surgery and glucocorticoid treatment. Then, 60 mg of
prednisone a day was maintained for 6 weeks, with a progressive
dose reduction of 20%/week until discontinuation. This patient
is still undergoing secondary prophylaxis for RF with benzathine
penicillin G every 3 weeks for an indefinite time. She is presently
asymptomatic.
DISCUSSION
Rheumatic fever remains a leading cause of acquired cardiopathy
in many regions, such as South America (1), Africa (2), and India
(3). Acute RF is frequently asymptomatic, particularly rheumatic
myocarditis. The most common clinical manifestations are arthri-
tis and fever (3). RF and acute rheumatic myocarditis, in particular,
are underrepresented in the medical literature because RF is rare
in Europe and the United States; most of the literature on this
subject date to the 1950s. Recently, some quality studies from Aus-
tralia and the World Heart Federation have drawn attention to
this important and intriguing disease (4). Many patients who were
included in register-based programs were symptomatic. However,
there are a number of silent or undetected attacks of ARF, and those
patients with asymptomatic RHD can receive a huge benefit from
secondary prophylaxis. Therefore, creating screening programs to
detect asymptomatic cases is an effective strategy (5).
Still, ARF is a frequently underdiagnosed condition even in
patients with valvular heart disease in RHD endemic countries.
The histological finding of Aschoff bodies is the most charac-
teristic finding of rheumatic inflammation in the heart (6) and
effectively makes the diagnosis of acute rheumatic myocarditis.
Rheumatic myocarditis is a particular feature of acute rheumatic
carditis, which also encompasses rheumatic pericarditis and
rheumatic valvulitis. The incidental finding of Aschoff nodules
diagnoses acute rheumatic myocarditis, as was observed in our
patient.
In acute RHD, histological analyses have shown the presence of
dense valvular inflammatory infiltrates and Aschoff nodules in the
myocardium of 21% of patients. Infiltrating T-cells were mainly
CD4+ cells in heart tissue biopsies of patients with rheumatic
activity. In addition, CD4+ and CD8+ infiltrating T-cell clones
recognized streptococcal M peptides and cardiac tissue proteins.
These findings may open new possibilities of immunotherapy. In
addition, it was demonstrated that the surgical procedure during
the acute phase of the disease improved the quality of life of young
RHD patients (7).
The prevalence of Aschoff bodies in left atrial appendages
collected after elective surgery for valvular heart disease is well
documented in the twentieth-century literature. The mean fre-
quency of atrial specimens with Aschoff bodies is approximately
35% (Table 1). Even in more recent studies, the prevalence of
Aschoff bodies after elective surgery remained as high as 30% (8).
Most of these reports had no information on the clinical data of
those patients or whether they were using secondary prophylaxis
with benzathine penicillin G. A report by Virmani et al. (9) men-
tioned that only 1 of their 45 patients with Aschoff bodies in their
myocardial biopsies had symptoms compatible with acute RF, and
none of the patients had laboratorial evidence of rheumatic activ-
ity. The only clinical data that can be drawn from these studies
is that the finding of Aschoff bodies was more frequent in young
patients.
Acute rheumatic myocarditis has a different pathophysiology
from myocarditis of other etiologies. First, there is no massive
myocardial necrosis in rheumatic myocarditis – the elevation of
cardiac troponins, for instance, is detected only with highly sen-
sitive troponin measurements (20), and histopathology reveals
no necrosis. This mild elevation of troponin found in rheumatic
patients may be the result of an inflammatory process with mini-
mal damage to the myocardial cell. Additionally, acute rheumatic
myocarditis does not lead to long-term ventricular dysfunction,
which is different from other etiologies of myocarditis such as
viral myocarditis, in which myocardial necrosis is evident on his-
tology and high-plasma levels of troponins are found. Myocardial
dysfunction in acute rheumatic myocarditis may be related to
local inflammation and the local secretion of proinflammatory
cytokines (21) with no permanent myocardial damage.
There are authors who do not consider rheumatic myocarditis
to exist because there is no evidence of necrosis or high levels of tro-
ponins in its diagnosis (22, 23). Nonetheless, there is histopatho-
logical evidence of inflammatory findings in the myocardium
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Table 1 | Frequency of Aschoff bodies in specimens obtained after
elective cardiac surgery in various reports.
Reference Patient
number
Average age (years) Percentage with
Aschoff bodies (%)
(10) 15 36 67
(11) 12 n/a 25
(12) 11 n/a 36
(13) 18 36 44
(14) 43 34 74
(6)a 183 38 45
104 patients aged 20–39 years 63
77 patients aged >40 years 16
(15) 40 13 55
(16) 400 34 19
(17) 113 n/a 26
(18) 175 35 64
(19)a 316 178 patients aged ≤40 years 52
117 patients aged >40 years 27
(9) 191 42 21
(8) 100 n/a 35
n/a, not available.
aThere were missing data on age in 2 patients in the paper by Decker et al. (6)
and in 21 patients in the paper by Ruebner et al. (19).
(such as Aschoff nodules and mononuclear infiltrates). More-
over, current guidelines recommend that glucocorticoids may be
considered for patients with heart failure in whom acute cardiac
surgery is not indicated (24), although this recommendation was
not tested in recent randomized trials, it is supported by clinical
experience. It should be noted that clinical trials of glucocorticoids
for rheumatic carditis treatment have been conducted for over
50 years (25). Finally, there are reports of patients with the diag-
nosis of acute RF that have dilatation and worsening of ventricular
function independently of the presence of valvular regurgitation
(26), suggesting that a primary myocardial inflammation is the
origin of the ventricular dysfunction.
None of these histopathological studies have included any men-
tion on the prognosis of the patients or whether they were given
corticosteroids or secondary prophylaxis for RF. Crucially, none of
these reports mentioned if the patient was undergoing secondary
prophylaxis for RF before cardiac surgery; the findings of almost a
third of the biopsies with Aschoff nodules suggested that none of
these patients were using prophylaxis for RF. Our experience sug-
gests that in a setup in which all patients below 40 years of age are
using secondary prophylaxis for RF, Aschoff bodies occur much
less frequently than reported in the literature.
Because acute rheumatic myocarditis is frequently asympto-
matic (27), its diagnosis is difficult and requires a high-suspicion
rate. Rheumatic patients with acute myocarditis often present
mild symptoms such as tachycardia or mild worsening of heart
failure symptoms. These symptoms are frequently attributed to
worsening of the valvular heart disease or another cause of decom-
pensation, such as volume or salt overload. In this case report,
the patient experienced tachycardia and exertional dyspnea that
include symptoms that may be observed in many conditions after
cardiac surgery, such as pericarditis, reduced left ventricle ejection
fraction, and infection. However, those symptoms may also be
suggestive of myocarditis, provided that other causes have been
excluded.
Even though most symptoms of myocarditis are mild, in
patients with severe LV end-diastolic pressure or volume over-
load due to valvular heart disease, acute rheumatic myocarditis
can be fatal (28).
Rheumatic heart disease patients have a degree of chronic low-
level inflammation (29) that must not be mistaken for acute
myocarditis: in acute rheumatic myocarditis, there is frequently
mild elevation of the inflammatory markers, which are within
the normal range in chronic RHD, and symptoms of worsening
symptoms or LV function may also occur. Additionally, in acute
rheumatic myocarditis, there is imaging evidence of myocardial
inflammation, as discussed below.
The diagnosis of acute rheumatic myocarditis is difficult and
frequently requires the use of multiple imaging techniques. An
echocardiography can reveal mild to moderate pericardial effu-
sion (rarely pericardial effusion or even pericardial tamponade).
Transesophageal echocardiography can sometimes show small
multiple vegetations on the edge of native valves, representing the
rheumatic verrucae that characterize the acute phase of the dis-
ease. Laboratorial exams show high-inflammatory markers, such
as the erythrocyte sedimentation rate and the C-reactive protein
(3). The highly sensitive C-reactive protein may increase in chronic
rheumatic heart disease, indicating that an inflammatory response
still persists in the chronic phase (30).
The 12-lead electrocardiogram might be helpful because the
first degree of an atrioventricular heart block is a sign of
myocarditis, but this is not very sensitive in identifying rheumatic
myocarditis.
Imaging techniques that highlight inflammation in the heart
are particularly useful for the diagnosis of acute rheumatic
myocarditis. Gallium-67 myocardium scintigraphy can be used
to demonstrate myocarditis and has been studied in the diagno-
sis of acute rheumatic patients (31). A good correlation has been
shown between a positive scintigraphy and a myocardial biopsy
for the diagnosis of active myocarditis. Positron-emission scintig-
raphy associated with tomography (PET-CT) is currently being
evaluated and appears to have a better sensitivity than the Gallium
scan in addition to a much better spatial resolution, which may
prove it to be an important diagnostic tool for the detection of
rheumatic myocarditis.
The real clinical and prognostic significance of Aschoff bodies
in myocardial biopsies of patients undergoing elective surgery for
valvular heart diseases is still unknown. However, if we consider
that these patients have active rheumatic myocarditis, glucocor-
ticoid treatment is indicated and can shorten the evolution of
the disease and the clinical symptoms of heart failure (32). Addi-
tionally, an extension of the secondary prophylaxis regimen is
warranted in these patients to prevent subsequent recurrences of
asymptomatic active RF.
In conclusion, acute rheumatic myocarditis is a difficult diag-
nosis that should be considered in any patient, including patients
who have just undergone valve surgery, with rheumatic valvular
heart disease who present with a sudden worsening of heart failure
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symptoms or rapid-onset ventricular dysfunction, particularly if
the patient is not on secondary prophylaxis for RF.
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